Increased serum tumor necrosis factor receptor-associated factor-6 expression in patients with non-metastatic triple-negative breast cancer

By              

Oncology Letters, Vol. 9, Iss. 6, 2015-01 ,pp. : 2819-2824

Spandidos Publications

Access to resources Recommend Favorite

Elevated Luteinizing Hormone in Serum, Breast Cancer Tissue, and Normal Breast Tissue from Breast Cancer Patients

By Silva E.G.  

Breast Cancer Research and Treatment, Vol. 76, Iss. 2, 2002-11 ,pp. : 125-130

Springer Publishing Company

Access to resources Recommend Favorite

Patients’ understanding of their own disease and survival potential in patients with metastatic breast cancer

By Okamura H.  

Breast Cancer Research and Treatment, Vol. 61, Iss. 2, 2000-05 ,pp. : 131-137

Springer Publishing Company

Access to resources Recommend Favorite

Pain Control with Zoledronic Acid in Patients with Breast Cancer and Metastatic Bone Disease

By Cinzia Nigro   Michela Donadio   Mara Ardine   Alessandra Beano   Marinella Mistrangelo   Zaira Coccorullo   Oscar Bertetto  

American Journal of Cancer, Vol. 3, Iss. 4, 2004-01 ,pp. : 257-263

Adis International

Access to resources Recommend Favorite

Serum epidermal growth factor is associated with prognosis and hormone receptor status in patients with HER2-positive metastatic breast cancer treated with first-line trastuzumab plus taxane chemotherapy

By Kim Ji-Won   Kim Jee   Im Seock-Ah   Lee Kyung-Hun   Kim Jin-Soo   Kim Tae-Yong   Han Sae-Won   Jeon Yoon   Oh Do-Youn   Kim Tae-You   Park In  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 5, 2013-11 ,pp. : 1023-1029

Springer Publishing Company

Access to resources Recommend Favorite